Laure-hÉlÈne Mercier, Msc, Mba
Executive Vice President and Chief Financial Offic
immunology
pharma
Burundi
Biography
Laure-Hélène Mercier, Chief Financial Officer, joined Innate Pharma in 2007 and was appointed Chief Financial Officer on December 30, 2016. Prior to her current position, Ms. Mercier served as Executive Vice President, Finance beginning in October 2016 and was previously our Director of Investor Relations. Prior to joining, Ms. Mercier held positions as an equity analyst at Oddo Securities and Natexis Bleichroeder. She has a MSc in Neurosciences from Université Aix-Marseille and a MBA from ESSEC Business School.
Research Interest
Laure-Hélène Mercier, Chief Financial Officer, joined Innate Pharma in 2007 and was appointed Chief Financial Officer on December 30, 2016. Prior to her current position, Ms. Mercier served as Executive Vice President, Finance beginning in October 2016 and was previously our Director of Investor Relations. Prior to joining, Ms. Mercier held positions as an equity analyst at Oddo Securities and Natexis Bleichroeder. She has a MSc in Neurosciences from Université Aix-Marseille and a MBA from ESSEC Business School.
